wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38679997-E8C5F0D6-2656-47BD-9057-DB03BE05ABEC
Q38679997-E8C5F0D6-2656-47BD-9057-DB03BE05ABEC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38679997-E8C5F0D6-2656-47BD-9057-DB03BE05ABEC
The Role of SGLT-2 Inhibitors as Part of Optimal Medical Therapy in Improving Cardiovascular Outcomes in Patients with Diabetes and Coronary Artery Disease.
P2860
Q38679997-E8C5F0D6-2656-47BD-9057-DB03BE05ABEC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38679997-E8C5F0D6-2656-47BD-9057-DB03BE05ABEC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a53d843a878a485bdf2866d36ae07f59131c0649
P2860
Pharmacodynamic effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, from a randomized study in patients with type 2 diabetes.